お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、ファビピラビルの世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にファビピラビル市場を分類しています。
本レポートでは世界のファビピラビル市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：ChemRar Group、Glenmark、Fujifilm、Dr. Reddy、R-Pharma、Cipla、Lupin、Sun Pharma、Hisun Pharm

レポートはファビピラビルの主要生産者を調査し、主要地域や国の消費状況も提供します。ファビピラビルの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Brand Drug
    Generic Drug

用途別の市場セグメント：
    Influenza Viruses
    COVID-19
    Others

本レポートの詳細内容
本レポートは、世界のファビピラビル市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてファビピラビル市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）のファビピラビル生産量、成長率、市場シェアを調査している。

二. 消費面では、ファビピラビルの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーのファビピラビル売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界のファビピラビル市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本ファビピラビルのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：ファビピラビルのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： ファビピラビルの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおけるファビピラビルの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章ファビピラビルメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：ファビピラビルの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：ファビピラビルの主要メーカーの概要を提供し、製品の説明と仕様、ファビピラビルの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：ファビピラビルの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.
The global Favipiravir market is projected to grow from US$ 50 million in 2024 to US$ 11 million by 2030, at a Compound Annual Growth Rate (CAGR) of -22.0% during the forecast period.
In the global Favipiravir market, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma are the key players. The global 5 Largest Favipiravir Players account for 70% market share by revenue. India hold a key market revenue share of the Favipiravir market which account for 73%. The classification of Favipiravir includes Brand Drug and Generic Drug. Brand Drug accounted for a share of 16% in the global Favipiravir market. Favipiravir is widely used for Influenza Viruses, COVID-19, etc. The most proportion of Favipiravir is used for COVID-19 and the proportion is 97%.
Report Covers:
This report presents an overview of global market for Favipiravir, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Favipiravir, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Favipiravir, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Favipiravir sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Favipiravir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Favipiravir sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    ChemRar Group
    Glenmark
    Fujifilm
    Dr. Reddy
    R-Pharma
    Cipla
    Lupin
    Sun Pharma
    Hisun Pharm

Segment by Type
    Brand Drug
    Generic Drug

Segment by Application
    Influenza Viruses
    COVID-19
    Others

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Favipiravir in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Favipiravir manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Favipiravir sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Favipiravir Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Brand Drug
    Table 3. Major Manufacturers of Generic Drug
    Table 4. Global Favipiravir Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Favipiravir Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Favipiravir Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Favipiravir Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Favipiravir Revenue Market Share by Region (2019-2024)
    Table 9. Global Favipiravir Revenue Market Share by Region (2025-2030)
    Table 10. Global Favipiravir Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Favipiravir Sales by Region (2019-2024) & (K Units)
    Table 12. Global Favipiravir Sales by Region (2025-2030) & (K Units)
    Table 13. Global Favipiravir Sales Market Share by Region (2019-2024)
    Table 14. Global Favipiravir Sales Market Share by Region (2025-2030)
    Table 15. Global Favipiravir Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Favipiravir Sales Share by Manufacturers (2019-2024)
    Table 17. Global Favipiravir Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Favipiravir Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Favipiravir, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Favipiravir Price by Manufacturers 2019-2024 (US$/Unit)
    Table 21. Global Favipiravir Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Favipiravir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Favipiravir as of 2023)
    Table 23. Global Key Manufacturers of Favipiravir, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Favipiravir, Product Offered and Application
    Table 25. Global Key Manufacturers of Favipiravir, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Favipiravir Sales by Type (2019-2024) & (K Units)
    Table 28. Global Favipiravir Sales by Type (2025-2030) & (K Units)
    Table 29. Global Favipiravir Sales Share by Type (2019-2024)
    Table 30. Global Favipiravir Sales Share by Type (2025-2030)
    Table 31. Global Favipiravir Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Favipiravir Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Favipiravir Revenue Share by Type (2019-2024)
    Table 34. Global Favipiravir Revenue Share by Type (2025-2030)
    Table 35. Favipiravir Price by Type (2019-2024) & (US$/Unit)
    Table 36. Global Favipiravir Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 37. Global Favipiravir Sales by Application (2019-2024) & (K Units)
    Table 38. Global Favipiravir Sales by Application (2025-2030) & (K Units)
    Table 39. Global Favipiravir Sales Share by Application (2019-2024)
    Table 40. Global Favipiravir Sales Share by Application (2025-2030)
    Table 41. Global Favipiravir Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Favipiravir Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Favipiravir Revenue Share by Application (2019-2024)
    Table 44. Global Favipiravir Revenue Share by Application (2025-2030)
    Table 45. Favipiravir Price by Application (2019-2024) & (US$/Unit)
    Table 46. Global Favipiravir Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 47. US & Canada Favipiravir Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Favipiravir Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Favipiravir Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Favipiravir Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Favipiravir Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Favipiravir Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Favipiravir Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Favipiravir Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Favipiravir Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Favipiravir Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Favipiravir Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Favipiravir Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Favipiravir Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Favipiravir Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Favipiravir Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Favipiravir Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Favipiravir Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Favipiravir Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Favipiravir Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Favipiravir Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Favipiravir Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Favipiravir Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Favipiravir Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Favipiravir Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Favipiravir Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Favipiravir Sales by Country (2025-2030) & (K Units)
    Table 73. China Favipiravir Sales by Type (2019-2024) & (K Units)
    Table 74. China Favipiravir Sales by Type (2025-2030) & (K Units)
    Table 75. China Favipiravir Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Favipiravir Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Favipiravir Sales by Application (2019-2024) & (K Units)
    Table 78. China Favipiravir Sales by Application (2025-2030) & (K Units)
    Table 79. China Favipiravir Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Favipiravir Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Favipiravir Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Favipiravir Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Favipiravir Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Favipiravir Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Favipiravir Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Favipiravir Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Favipiravir Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Favipiravir Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Favipiravir Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Favipiravir Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Favipiravir Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Favipiravir Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Favipiravir Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Favipiravir Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Favipiravir Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Favipiravir Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Favipiravir Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Favipiravir Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Favipiravir Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Favipiravir Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Favipiravir Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Favipiravir Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Favipiravir Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Favipiravir Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Favipiravir Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Favipiravir Sales by Country (2025-2030) & (K Units)
    Table 107. ChemRar Group Company Information
    Table 108. ChemRar Group Description and Major Businesses
    Table 109. ChemRar Group Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. ChemRar Group Favipiravir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. ChemRar Group Recent Developments
    Table 112. Glenmark Company Information
    Table 113. Glenmark Description and Major Businesses
    Table 114. Glenmark Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Glenmark Favipiravir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Glenmark Recent Developments
    Table 117. Fujifilm Company Information
    Table 118. Fujifilm Description and Major Businesses
    Table 119. Fujifilm Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Fujifilm Favipiravir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Fujifilm Recent Developments
    Table 122. Dr. Reddy Company Information
    Table 123. Dr. Reddy Description and Major Businesses
    Table 124. Dr. Reddy Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Dr. Reddy Favipiravir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Dr. Reddy Recent Developments
    Table 127. R-Pharma Company Information
    Table 128. R-Pharma Description and Major Businesses
    Table 129. R-Pharma Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. R-Pharma Favipiravir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. R-Pharma Recent Developments
    Table 132. Cipla Company Information
    Table 133. Cipla Description and Major Businesses
    Table 134. Cipla Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Cipla Favipiravir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Cipla Recent Developments
    Table 137. Lupin Company Information
    Table 138. Lupin Description and Major Businesses
    Table 139. Lupin Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Lupin Favipiravir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Lupin Recent Developments
    Table 142. Sun Pharma Company Information
    Table 143. Sun Pharma Description and Major Businesses
    Table 144. Sun Pharma Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Sun Pharma Favipiravir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Sun Pharma Recent Developments
    Table 147. Hisun Pharm Company Information
    Table 148. Hisun Pharm Description and Major Businesses
    Table 149. Hisun Pharm Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 150. Hisun Pharm Favipiravir Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Hisun Pharm Recent Developments
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Favipiravir Distributors List
    Table 155. Favipiravir Customers List
    Table 156. Favipiravir Market Trends
    Table 157. Favipiravir Market Drivers
    Table 158. Favipiravir Market Challenges
    Table 159. Favipiravir Market Restraints
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Favipiravir Product Picture
    Figure 2. Global Favipiravir Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Favipiravir Market Share by Type in 2023 & 2030
    Figure 4. Brand Drug Product Picture
    Figure 5. Generic Drug Product Picture
    Figure 6. Global Favipiravir Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Favipiravir Market Share by Application in 2023 & 2030
    Figure 8. Influenza Viruses
    Figure 9. COVID-19
    Figure 10. Others
    Figure 11. Favipiravir Report Years Considered
    Figure 12. Global Favipiravir Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Favipiravir Revenue 2019-2030 (US$ Million)
    Figure 14. Global Favipiravir Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Favipiravir Revenue Market Share by Region (2019-2030)
    Figure 16. Global Favipiravir Sales 2019-2030 ((K Units)
    Figure 17. Global Favipiravir Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Favipiravir Sales YoY (2019-2030) & (K Units)
    Figure 19. US & Canada Favipiravir Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Favipiravir Sales YoY (2019-2030) & (K Units)
    Figure 21. Europe Favipiravir Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Favipiravir Sales YoY (2019-2030) & (K Units)
    Figure 23. China Favipiravir Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Favipiravir Sales YoY (2019-2030) & (K Units)
    Figure 25. Asia (excluding China) Favipiravir Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Favipiravir Sales YoY (2019-2030) & (K Units)
    Figure 27. Middle East, Africa and Latin America Favipiravir Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Favipiravir Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Favipiravir in the World: Market Share by Favipiravir Revenue in 2023
    Figure 30. Global Favipiravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Favipiravir Sales Market Share by Type (2019-2030)
    Figure 32. Global Favipiravir Revenue Market Share by Type (2019-2030)
    Figure 33. Global Favipiravir Sales Market Share by Application (2019-2030)
    Figure 34. Global Favipiravir Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Favipiravir Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Favipiravir Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Favipiravir Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Favipiravir Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Favipiravir Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Favipiravir Sales Share by Country (2019-2030)
    Figure 41. U.S. Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Favipiravir Sales Market Share by Type (2019-2030)
    Figure 44. Europe Favipiravir Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Favipiravir Sales Market Share by Application (2019-2030)
    Figure 46. Europe Favipiravir Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Favipiravir Revenue Share by Country (2019-2030)
    Figure 48. Europe Favipiravir Sales Share by Country (2019-2030)
    Figure 49. Germany Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 50. France Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 54. China Favipiravir Sales Market Share by Type (2019-2030)
    Figure 55. China Favipiravir Revenue Market Share by Type (2019-2030)
    Figure 56. China Favipiravir Sales Market Share by Application (2019-2030)
    Figure 57. China Favipiravir Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Favipiravir Sales Market Share by Type (2019-2030)
    Figure 59. Asia Favipiravir Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Favipiravir Sales Market Share by Application (2019-2030)
    Figure 61. Asia Favipiravir Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Favipiravir Revenue Share by Region (2019-2030)
    Figure 63. Asia Favipiravir Sales Share by Region (2019-2030)
    Figure 64. Japan Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 68. India Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Favipiravir Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Favipiravir Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Favipiravir Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Favipiravir Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Favipiravir Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Favipiravir Sales Share by Country (2019-2030)
    Figure 75. Brazil Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Favipiravir Revenue (2019-2030) & (US$ Million)
    Figure 80. Favipiravir Value Chain
    Figure 81. Favipiravir Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed